Skip to main content
  • Newsletters
  • Axios Pro
  • Axios Live
  • The Axios Show
Axios

Axios

Katherine Davis

Katherine Davis is a biotech reporter for Axios Pro Deals. She reports on venture capital, private equity and M&A transactions across the biotech sector.

  • email[email protected]

Stories

    • Biotech Deals

    May 14, 2026

    Biotech insiders pitch Richard Pazdur as next FDA commissioner

    Go deeper (1 min. read)
    • Biotech Deals

    May 13, 2026

    Makary's departure won't solve biotech uncertainty

    Go deeper (1 min. read)
    • Biotech Deals

    May 13, 2026

    NVision raises $55M Series B for quantum-enhanced MRI platform

    Go deeper (1 min. read)
    • Biotech Deals

    May 12, 2026

    Isomorphic Labs raises $2.1B for AI drug discovery

    Go deeper (<1 min. read)
    • Biotech Deals

    May 8, 2026

    Biopharma IPOs bounce back — cautiously

    Go deeper (1 min. read)

Newsletter editions

    • Newsletter

    May 16, 2026

    🧬 Biotech weekly

    Go deeper (2 min. read)
    • Newsletter

    May 9, 2026

    🧬 Biotech weekly

    Go deeper (4 min. read)
    • Newsletter

    May 7, 2026

    💭 Thought bubble: Biopharma buying binge

    Go deeper (1 min. read)
    • Newsletter

    May 2, 2026

    🧬 Biotech weekly

    Go deeper (4 min. read)
    • Newsletter

    Apr 25, 2026

    🧬 Biotech weekly

    Go deeper (2 min. read)
Smarter, faster on what matters.
Explore Axios Newsletters
  • About Axios
  • Advertise with us
  • Careers
  • Contact us
  • Newsletters
  • Axios Live
  • Axios HQ
  • Privacy policy
  • Terms of use
Axios Homepage

Axios Media Inc., 2026